All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
Join our
Treating classical Hodgkin lymphoma: Spotlight on targeted therapies
with Gilles Salles, Paul Bröckelmann, and Ann S. LaCasce
Saturday, November 2, 2024
8:50-9:50 CET
This independent educational activity is sponsored by Takeda. All content is developed independently by the faculty. Funders are allowed no direct influence on the content of this activity.
The Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lymphoma & CLL Hub is an independent medical education platform, sponsored by Beigene and Roche, and supported through educational grants from Bristol Myers Squibb, Ipsen Biopharmaceuticals, Pfizer, and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. View funders.
Doctor Astrid Pavlovsky is the Medical Director of the Pavlovsky Center and staff member in the Hematology Department in FUNDALEU, Buenos Aires, AR. She is a specialist in internal medicine and hematology. Dr Pavlovsky graduated from medical school with honors at the Universidad del Salvador, AR, in 1997. She completed training in internal medicine at Hospital Italiano de Buenos Aires, AR, for five years and continued her training in FUNDALEU as a Fellow in Hematology in Buenos Aires, AR.
Dr Pavlovsky is actively involved in different clinical trials as Principal Investigator or Co-Investigator in lymphoproliferative diseases. She is currently the Principal Investigator in a clinical trial for Hodgkin lymphoma.
Positions of responsibility/awards: